Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

China Says GlaxoSmithKline Deserves an “Astronomical” Fine

publication date: Sep 5, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
China’s Ministry of Public Security, the agency in charge of the investigation into GlaxoSmithKline’s alleged bribery scheme, said on its website that GSK deserved an “astronomical fine” for its violations. Earlier, one of the four GSK China officials detained in the probe said the company’s China head set very high targets for revenues. The goals were so high, she asserted, that managers could not meet them without offering financial inducements. More details....

Stock Symbol: (NYSE: GSK)

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...